Literature DB >> 15010385

Sparing of the penile bulb and proximal penile structures with intensity-modulated radiation therapy for prostate cancer.

J Kao1, J Turian, A Meyers, R J Hamilton, B Smith, S Vijayakumar, A B Jani.   

Abstract

Quality of life is an important consideration in the treatment of early prostate cancer. Laboratory and clinical data suggest that higher radiation doses delivered to the bulb of penis and proximal penile structures correlates with higher rates of post-radiation impotence. The goal of this investigation was to determine if intensity-modulated radiation therapy (IMRT) spares dose to the penile bulb while maintaining coverage of the prostate. 10 consecutive patients with clinically organ confined prostate cancer were planned with 3D conformal radiation therapy (3D-CRT) or IMRT to give a dose of 74 Gy without specifically constraining the plans to spare the penile bulb. All 10 patients were ultimately treated with IMRT. Dose-volume histograms were evaluated and the doses to prostate, rectum, bladder and penile bulb were compared. IMRT reduced the mean penile bulb doses compared with 3D-CRT (33.2 Gy vs 48.9 Gy, p<0.001), the percentage of penile bulb receiving over 40 Gy (37.7% vs 67.2%, p<0.001) and the dose received by >95% of penile bulb (5.3 Gy vs 11.7 Gy, p=0.003). Maximum penile bulb doses were higher with IMRT (81.2 Gy vs 73.1 Gy, p<0.001) although the volume of this high dose region was small. Both methods resulted in similar coverage of the prostate. The volume of rectum receiving 70 Gy was significantly reduced with IMRT (18.4% vs 21.9%, p=0.003) but the volumes of bladder receiving 70 Gy were similar (p=0.3). IMRT may potentially reduce long term sexual morbidity by reducing the dose to the majority of the penile bulb.

Entities:  

Mesh:

Year:  2004        PMID: 15010385     DOI: 10.1259/bjr/37893924

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  8 in total

1.  Penile bulb sparing in prostate cancer radiotherapy : Dose analysis of an in-house MRI system to improve contouring.

Authors:  F Böckelmann; M Hammon; S Lettmaier; R Fietkau; C Bert; F Putz
Journal:  Strahlenther Onkol       Date:  2018-10-12       Impact factor: 3.621

2.  Influence of vascular comorbidities and race on erectile dysfunction after prostate cancer radiotherapy.

Authors:  Yuefeng Wang; Tian Liu; Peter J Rossi; Deborah Watkins-Bruner; Wayland Hsiao; Sherrie Cooper; Xiaofeng Yang; Ashesh B Jani
Journal:  J Sex Med       Date:  2013-06-06       Impact factor: 3.802

3.  Reproducibility in contouring the neurovascular bundle for prostate cancer radiation therapy.

Authors:  Richard J Cassidy; Sherif G Nour; Tian Liu; Jeffrey M Switchenko; Sibo Tian; Matthew J Ferris; Robert H Press; Jim Zhong; Mustafa Abugideiri; Peter J Rossi; Ashesh B Jani
Journal:  Pract Radiat Oncol       Date:  2017-08-03

Review 4.  Erectile dysfunction following radiotherapy and brachytherapy for prostate cancer: pathophysiology, prevention and treatment.

Authors:  Cem Akbal; Ilker Tinay; Ferruh Simşek; Levent N Turkeri
Journal:  Int Urol Nephrol       Date:  2008       Impact factor: 2.370

5.  Statistical analysis of IMRT dosimetry quality assurance measurements for local delivery guideline.

Authors:  Jin Beom Chung; Jae Sung Kim; Sung Whan Ha; Sung-Joon Ye
Journal:  Radiat Oncol       Date:  2011-03-28       Impact factor: 3.481

6.  Inter-observer variability in contouring the penile bulb on CT images for prostate cancer treatment planning.

Authors:  Lucia Perna; Cesare Cozzarini; Eleonora Maggiulli; Gianni Fellin; Tiziana Rancati; Riccardo Valdagni; Vittorio Vavassori; Sergio Villa; Claudio Fiorino
Journal:  Radiat Oncol       Date:  2011-09-24       Impact factor: 3.481

7.  Longitudinal Changes in U.S. Parameters of Neurovascular Bundles Suggest Mechanism for Radiation-Induced Erectile Dysfunction.

Authors:  James R Janopaul-Naylor; Tian Liu; Boran Zhou; Xiaofeng Yang; Neal S McCall; Pretesh R Patel; Akanksha Mehta; Sherif G Nour; Ashesh B Jani
Journal:  Adv Radiat Oncol       Date:  2022-03-19

Review 8.  Intensity-modulated radiotherapy for prostate cancer.

Authors:  Ben W Fischer-Valuck; Yuan James Rao; Jeff M Michalski
Journal:  Transl Androl Urol       Date:  2018-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.